NEW YORK, March 28, 2017 /PRNewswire/ --
On Monday, benchmark US indices were in mixed colors as the NASDAQ Composite closed the trading session up 0.20%; the Dow Jones Industrial Average edged 0.22% lower; and the S&P 500 was down 0.10%. US markets saw a mixed session as 4 sectors closed in green, 3 sectors finished in red, and 2 sectors ended flat for the day. Pre-market today, Stock-Callers.com reviews these four Medical Laboratories & Research stocks: VWR Corporation (NASDAQ: VWR), Laboratory Corporation of America Holdings (NYSE: LH), Bruker Corporation (NASDAQ: BRKR), and PerkinElmer Inc. (NYSE: PKI). Learn more about these stocks by accessing their free research reports at:
On Monday, shares in Radnor, Pennsylvania-based VWR Corp. recorded a trading volume of 408,449 shares. The stock ended the day 0.99% higher at $27.58. Shares of the Company, which together with its subsidiaries, operates as an independent provider of laboratory products, services, and solutions to the life science, general research, and applied markets, are trading at a PE ratio of 24.54. VWR's stock has gained 11.43% in the last three months and 6.57% in the previous one year. The Company's shares are trading above its 50-day and 200-day moving averages by 3.43% and 0.04%, respectively. Furthermore, VWR's shares have a Relative Strength Index (RSI) of 53.72. Free research report on VWR is available at:
Laboratory Corp. of America
Burlington, North Carolina headquartered Laboratory Corp. of America Holdings' stock finished Monday's session 0.37% higher at $142.53 with a total volume of 835,246 shares traded. Over the last three months and the previous one year, Laboratory Corp. of America's shares have gained 12.39% and 24.88%, respectively. The Company's shares are trading above its 50-day and 200-day moving averages by 3.08% and 6.34%, respectively. Shares of Laboratory Corp., which operates as an independent clinical laboratory company worldwide, are trading at a PE ratio of 20.37. In addition, the stock has an RSI of 55.70.
On March 07th, 2017, research firm Barclays reiterated its 'Overweight' rating on the Company's stock with an increase of the target price from $165 a share to $175 a share. The complimentary research report on LH can be downloaded at:
Billerica, Massachusetts headquartered Bruker Corp.'s stock fell 1.98%, to close the day at $22.73. The stock recorded a trading volume of 981,781 shares, which was above its three months average volume of 695,570 shares. Bruker's shares have gained 6.39% in the last three months. The Company's shares are trading 4.10% and 0.11% below its 50-day and 200-day moving averages, respectively. Shares of the Company, which develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions worldwide, are trading at a PE ratio of 23.93. Additionally, the stock has an RSI of 39.21. Visit us today and access our complete research report on BRKR at:
On Monday, shares in Waltham, Massachusetts headquartered PerkinElmer Inc. ended the session 0.89% higher at $58.03 with a total volume of 1.32 million shares traded. PerkinElmer's shares have advanced 5.43% in the last one month and 11.02% in the previous three months. Furthermore, the stock has gained 20.78% in the past one year. Shares of the Company, which provides products, services, and solutions to the diagnostics, research, environmental, industrial, food, and laboratory services markets worldwide, are trading at a PE ratio of 27.26. The stock is trading 6.72% above its 50-day moving average and 8.46% above its 200-day moving average. Moreover, the Company's shares have an RSI of 70.15. Get free access to your research report on PKI at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email firstname.lastname@example.org. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA